Navigation Links
LifeNet Health(R) Unveils New Biomedical Spine Implant

VIRGINIA BEACH, Va., March 3 /PRNewswire-USNewswire/ -- LifeNet Health, a leading allograft bio-implant company, unveils the VertiGraft VG1(R) Cervical Bio-implant. This product has been engineered for anterior cervical fusion surgery to treat neck pain and cervical pathologies.

The new VG1(R) Cervical Bio-implant was co-developed by LifeNet Health and DePuy Spine(TM), and is exclusively represented in the U.S. by DePuy Spine.

"VG1(R) Cervical is an exciting addition to our VertiGraft spine specialty bio-implant portfolio. Many surgery centers and hospitals do not have access to the ultra low-temperature freezers needed to store frozen allograft. VG1 Cervical is freeze-dried so it can be stored at room temperature giving our customers convenient, room-temperature storage combined with the very high quality standards they demand. This new VG1(R) Cervical bio-implant will meet the surgeon's needs and benefit the patient by making very high quality allograft bio-implants available to more hospitals and surgery centers," says Michael Hobert, LifeNet Health's VertiGraft Product Manager.

LifeNet Health's CEO Rony Thomas states, "LifeNet Health's VertiGraft portfolio is setting the standard in spine specialty allograft bio-implants. Our research and development teams have engineered this implant to provide the patient and the surgeon with the bio-implants they need. We want to maximize the chances of successful transplantation and we are proud to be able to provide the VG1(R) Cervical bio-implant as a solution."

LifeNet Health will exhibit the company's bio-implants at this year's American Academy of Orthopaedic Surgeons (AAOS) meeting, to be held in San Francisco March 5th through 8th. At AAOS, LifeNet Health will officially unveil the new VertiGraft VG1(R) Cervical. The LifeNet Health exhibit booth at the AAOS Annual Meeting in San Francisco will give surgeons a chance to learn more about LifeNet Health's product lines, its outstanding safety record and its unyielding commitment to quality. Since 1995, LifeNet Health has distributed 1 million bio-implants with no incidence of disease transmission linked to tissue screened and processed using LifeNet Health's proprietary Allowash XG(R) technology. "Surgeons can depend on us. We offer high-quality, safe bio-implants to save lives and restore health," adds Thomas.

LifeNet Health, founded in 1982, is a full service biomedical tissue banking system and a leading non-profit organ and tissue donation agency whose mission is saving lives and restoring health. LifeNet Health provides recovery and processing services for musculoskeletal and cardiovascular tissues, distributing more than 250,000 biomedical implants every year to restore health to patients around the world.

For additional information about LifeNet Health, visit

CONTACT: Dena Reynolds of LifeNet, 1-800-847-7831

Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. LifeNet Health Saves 303 Lives and Restores Health to 265,967 Patients in 2007
2. LifeNet Health and LOPA Announce a Partnership
3. LifeNet Health and IMS Announce Partnership
4. Maryland Science Center Unveils Anatomical Exhibition, Body Worlds 2, on Saturday, February 2
5. Research Using Thermo Fisher Scientific RNA-Interference Technology Unveils Potential New Targets for HIV Drugs
6. Champalimaud Foundation Unveils C-TRACER in Hyderabad, India
7. Highlands Behavioral Health Hospital Unveils New Substance Abuse Detox Program
8. Siemens Unveils New Digital Mammography System for Optimized Screening
9. Nikon Unveils the Eclipse Ti Inverted Microscope Series at The Society for Neroscience Annual Meeting
10. SeqWright Unveils ABI SOLiD(TM) Next Generation Genetic Analysis System
11. UniCare Unveils Community Resource Center in Topeka to Serve Medicaid Enrollees
Post Your Comments:
(Date:11/25/2015)... November 25, 2015 Studies reveal ... human plaque and pave the way for more effective treatment ... cats     --> ... diagnosed health problems in cats, yet relatively little was understood ... collaborative studies have been conducted by researchers from the WALTHAM ...
(Date:11/25/2015)... 25, 2015 Orexigen® Therapeutics, Inc. (Nasdaq: ... a fireside chat discussion at the Piper Jaffray 27th ... . The discussion is scheduled for Wednesday, December 2, ... .  A replay will be available for 14 days ... , Julie NormartVP, Corporate Communications and Business Development , ...
(Date:11/24/2015)... 2015 Cepheid (NASDAQ: CPHD ) today ... following conference, and invited investors to participate via webcast. ...      Tuesday, December 1, 2015 at 11.00 a.m. Eastern Time ...      Tuesday, December 1, 2015 at 11.00 a.m. Eastern Time ... New York, NY      Tuesday, December 1, 2015 ...
(Date:11/24/2015)... 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: ... behalf of the Toronto Stock Exchange, confirms that as ... no corporate developments that would cause the recent movements ... --> About Aeterna Zentaris Inc. ... --> Aeterna Zentaris is a specialty biopharmaceutical company ...
Breaking Biology Technology:
(Date:11/12/2015)... 11, 2015   Growing need for low-cost, ... has been paving the way for use of ... discrete analytes in clinical, agricultural, environmental, food and ... used in medical applications, however, their adoption is ... to continuous emphasis on improving product quality and ...
(Date:11/10/2015)... Nov. 10, 2015 About ... that helps to identify and verify the identity ... considered as the secure and accurate method of ... a particular individual because each individual,s signature is ... especially when dynamic signature of an individual is ...
(Date:11/4/2015)... ALBANY, New York , November 4, 2015 /PRNewswire/ ... According to a new market report published by Transparency ... Size, Share, Growth, Trends and Forecast 2015 - 2022", ... value of US$ 30.3 bn by 2022. The market ... during the forecast period from 2015 to 2022. Rising ...
Breaking Biology News(10 mins):